Potential Psychiatric Uses for MDMA
Clinical Pharmacology & Therapeutics November 10, 2016 Bb Yazar‐klosinski, Mc Mithoefer 81 citations
Phase II trials of MDMA-assisted psychotherapy show initial safety and efficacy for treating PTSD, with potential expansion to depression and anxiety disorders. In this model, single doses of MDMA are given within a psychotherapy framework, unlike daily drug administration without therapy. This approach could benefit from accelerated regulatory pathways like the FDA Breakthrough Therapy Designation to efficiently test these novel treatments.